In a 67-year-old woman presenting with altered mental status and suspected psychotropic polypharmacy, what additional laboratory and imaging studies should be obtained to evaluate reversible causes?

Additional Testing for 67-Year-Old Woman with AMS and Suspected Psychotropic Polypharmacy

Based on your patient's presentation and existing workup, you should obtain an EEG to evaluate for nonconvulsive seizures and a medication level panel (if available for her psychotropic agents), while the already-completed head CT, basic metabolic panel, and ECG have appropriately ruled out the most immediately life-threatening causes.

Critical Analysis of Completed Studies

Your initial workup has already addressed several key reversible causes:

• Head CT (completed): Appropriately obtained given AMS presentation. While yield is only 9.8% for AMS complaints 1, this was necessary to exclude intracranial hemorrhage, stroke, or mass lesions
• ECG shows QTc 457 msec: Borderline prolonged, concerning given polypharmacy context. Many psychotropics prolong QT interval, increasing arrhythmia risk
• Metabolic panel reveals:
  • Hypokalemia (2.9) - can worsen QT prolongation and cause confusion
  • Stage 3 CKD (eGFR 33) - significantly impairs drug clearance, increasing toxicity risk
  • Elevated AST (96) with normal ALT - may suggest drug-induced hepatotoxicity or other systemic process

Essential Additional Testing

High Priority (Obtain Immediately)

1. Electroencephalography (EEG)

• Nonconvulsive seizures occur in 8-37% of unexplained AMS cases and are easily missed clinically 1, 2
• Particularly important in elderly patients with polypharmacy who may have lowered seizure threshold
• Can also identify diffuse slowing patterns suggesting toxic-metabolic encephalopathy

2. Serum Psychotropic Drug Levels

• If your patient takes lithium, valproate, carbamazepine, or other agents with available levels, obtain these immediately
• Renal dysfunction (eGFR 33) dramatically increases risk of supratherapeutic levels 3
• Even "therapeutic" doses can become toxic with declining renal function

3. Ammonia Level

• Elevated in hepatic encephalopathy, which your elevated AST suggests as possible
• Can also be elevated with valproate toxicity

Moderate Priority (Obtain During Admission)

4. Vitamin B12 and Thiamine Levels

• B12 deficiency causes cognitive impairment in elderly 4
• Thiamine deficiency (Wernicke encephalopathy) is a reversible cause of AMS 1
• Both are common in elderly with poor nutrition or polypharmacy

5. Urinalysis with Culture (Already completed - review results)

• UTI is the most common reversible cause of delirium in elderly women
• Your UA shows 1+ protein and 0-4 WBCs - low suspicion but await culture results

6. Comprehensive Toxicology Screen

• Urine drug screen for undisclosed substances
• Acetaminophen and salicylate levels (common co-ingestions)

What You Do NOT Need

Lumbar Puncture: Not indicated unless fever, meningismus, or immunocompromised state develops. Your patient is afebrile with normal WBC 2

MRI Brain: Reserve for if CT and initial workup are unrevealing and AMS persists. Current guidelines support CT as first-line with MRI for selected cases 1

Repeat Imaging: Your completed CT head, chest X-ray, and CT abdomen/pelvis are sufficient unless clinical deterioration occurs

Critical Management Considerations

Immediate Actions Based on Current Labs

1. Correct hypokalemia aggressively - target >4.0 to reduce QT prolongation risk and improve mental status
2. Review ALL medications with pharmacy for:
   • Renally-dosed adjustments (eGFR 33 requires dose reduction for most psychotropics)
   • QT-prolonging agents (consider discontinuation or dose reduction)
   • Anticholinergic burden (strongly associated with delirium in elderly) 5
   • Serotonergic agents (risk of serotonin syndrome with polypharmacy) 3

Common Pitfalls to Avoid

• Do not assume psychiatric history explains current AMS: 63% of new psychiatric presentations in ED have medical etiology 4. Even with known psychiatric history, elderly patients with AMS require full medical evaluation
• Do not overlook drug-drug interactions: Your patient's renal dysfunction creates a "perfect storm" for psychotropic toxicity 6, 3
• Do not order "routine" extensive lab panels: Selective testing based on clinical findings has better yield than shotgun approach 4. False positives (8x more common than true positives) lead to unnecessary workups

Risk Stratification

Your patient has multiple high-risk features for organic causes of AMS 1:

• Age >65
• Chronic kidney disease with reduced drug clearance
• Polypharmacy
• Borderline QT prolongation
• Electrolyte abnormality

The combination of psychotropic polypharmacy and stage 3 CKD makes drug toxicity the most likely reversible cause 3. Medication rationalization should occur simultaneously with diagnostic workup 6.